Literature DB >> 20047972

Malignant mesothelioma.

R M Rudd1.   

Abstract

INTRODUCTION: Mesothelioma is a malignant tumour of the pleura or peritoneum caused by asbestos. It is increasing in frequency and the prognosis remains grim, with average survival around 1 year. SOURCES OF DATA: Medical literature and personal experience. AREAS OF AGREEMENT: Amphibole fibres are far more potent than chrysotile in causing mesothelioma. AREAS OF CONTROVERSY: A minority view suggests that mesotheliomas in those exposed to chrysotile are caused only by tremolite (an amphibole) which contaminates chrysotile. There is a hypothesis, for which evidence is weakening, that Simian virus 40 may cause mesothelioma. GROWING POINTS: There is emerging evidence of genetic variation in susceptibility to fibre carcinogenesis. There are developments in treatment, particularly chemotherapy with pemetrexed and cisplatin which prolongs survival and helps symptoms. AREAS TIMELY FOR DEVELOPING RESEARCH: Targeted agents for treatment are under investigation and may improve the outlook. The role of radical and palliative surgery requires clarification.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20047972     DOI: 10.1093/bmb/ldp047

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  24 in total

1.  A case report of metastasis of malignant mesothelioma to the oral gingiva.

Authors:  Stephanie Moser; Marc Beer; Georg Damerau; Heinz-Theo Lübbers; Klaus W Grätz; Astrid L Kruse
Journal:  Head Neck Oncol       Date:  2011-04-22

2.  Mesothelioma: a review.

Authors:  Frank E Mott
Journal:  Ochsner J       Date:  2012

Review 3.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

Review 4.  Clinical diagnosis of malignant pleural mesothelioma.

Authors:  Andrea Bianco; Tullio Valente; Maria Luisa De Rimini; Giacomo Sica; Alfonso Fiorelli
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

5.  Enhanced morphological transformation of human lung epithelial cells by continuous exposure to cellulose nanocrystals.

Authors:  E R Kisin; N Yanamala; D Rodin; A Menas; M Farcas; M Russo; S Guppi; T O Khaliullin; I Iavicoli; M Harper; A Star; V E Kagan; A A Shvedova
Journal:  Chemosphere       Date:  2020-02-13       Impact factor: 7.086

6.  Cutaneous Presentation of Mesothelioma With a Sarcomatoid Transformation.

Authors:  Nikolai Klebanov; Bobby Y Reddy; Sameera Husain; David N Silvers; Marc E Grossman; Hensin Tsao
Journal:  Am J Dermatopathol       Date:  2018-05       Impact factor: 1.533

7.  Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.

Authors:  M Cioce; F Ganci; V Canu; A Sacconi; F Mori; C Canino; E Korita; B Casini; G Alessandrini; A Cambria; M A Carosi; R Blandino; V Panebianco; F Facciolo; P Visca; S Volinia; P Muti; S Strano; C M Croce; H I Pass; G Blandino
Journal:  Oncogene       Date:  2013-11-18       Impact factor: 9.867

8.  Automated ancillary cancer history classification for mesothelioma patients from free-text clinical reports.

Authors:  Richard A Wilson; Wendy W Chapman; Shawn J Defries; Michael J Becich; Brian E Chapman
Journal:  J Pathol Inform       Date:  2010-10-11

9.  Identification of prognostic and bone metastasis​-related alternative splicing signatures in mesothelioma.

Authors:  Runzhi Huang; Zixuan Zheng; Sijia Liu; Penghui Yan; Dianwen Song; Huabin Yin; Peng Hu; Xiaolong Zhu; Zhengyan Chang; Yihan Liu; Juanwei Zhuang; Tong Meng; Zongqiang Huang; Jie Zhang
Journal:  Cancer Med       Date:  2021-05-26       Impact factor: 4.452

10.  A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion.

Authors:  Rumeng Gu; Luxi Jiang; Ting Duan; Chun Chen; Shengchang Wu; Deguang Mu
Journal:  Onco Targets Ther       Date:  2021-07-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.